Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
List of antiandrogens
This is a list of antiandrogens, or drugs that prevent the effects of androgens like testosterone and dihydrotestosterone (DHT). It includes direct antagonists of the androgen receptor (AR), androgen synthesis inhibitors like 5α-reductase inhibitors and CYP17A1 inhibitors, and antigonadotropins like GnRH analogues, estrogens, and progestogens. In addition, it includes both steroidal antiandrogen (SAAs) and nonsteroidal antiandrogen (NSAAs). Only antiandrogens that have been marketed are included in this list.
Androgen receptor antagonists
Steroidal antiandrogens
- 17α-Hydroxyprogesterone derivatives
- 19-Norprogesterone derivatives
- 19-Nortestosterone derivatives
- 17α-Spirolactone derivatives
- Others
Note that in addition to acting as AR antagonists, most SAAs also act as potent progestogens and therefore antigonadotropins.
Note that this list does not include pure progestogens, only SAAs also acting as AR antagonists.
Nonsteroidal antiandrogens
- First-generation
- Second-generation
- Others/non-generational
Note that, in contrast to most SAAs, NSAAs are pure/selective AR antagonists with no antigonadotropic activity.
Androgen synthesis inhibitors
CYP17A1 inhibitors
CYP11A1 (P450scc) inhibitors
5α-Reductase inhibitors
These drugs selectively inhibit the synthesis of DHT without affecting that of testosterone.
Antigonadotropins
- Estrogens (e.g., estradiol (and its esters), ethinylestradiol, conjugated estrogens, diethylstilbestrol)
-
GnRH analogues
- GnRH agonists (e.g., goserelin, leuprorelin)
- GnRH antagonists (e.g., cetrorelix)
- Progestogens (e.g., chlormadinone acetate, cyproterone acetate, gestonorone caproate, medroxyprogesterone acetate, megestrol acetate)
See also
GnRH and gonadotropins
| |||||
---|---|---|---|---|---|
GnRH modulators (incl. analogues) |
|
||||
Gonadotropins |
|
||||
Others (indirect) |
|
||||
|
AR |
|
||||||
---|---|---|---|---|---|---|---|
GPRC6A |
|
||||||